Skip to content
AiViva BioPharma
  • Home
AiViva BioPharma
  • Home

Archive for September 2022

Hannah Hershoff MD, PhD, has joined AiViva BioPharma as Chief Medical Officer

By AiViva BioPharma | September 1, 2022
Latest News With Binary Numbers in Background

Newport Beach, California – September 1, 2022 – AiViva Biopharma, a clinical stage biopharmaceutical company, today announced it has appointed Hannah Hershoff, M.D., Ph.D. as its Chief Medical Officer. In…

Read More

Recent Posts

  • Hannah Hershoff MD, PhD, has joined AiViva BioPharma as Chief Medical Officer
  • AiViva BioPharma Announces New Patent Received
  • AiViva BioPharma is recognized by Life Sciences Review as Top 20 Clinical-Stage Biopharmaceutical Company for 2022
  • AiViva BioPharma Initiates Phase 1/2 Clinical Trial of AIV001 for Nonmelanoma Skin Cancer
  • AiViva BioPharma Announces Positive Data from Phase 1/2a Clinical Trial of AIV001 for Dermal Scarring and Wound Healing  

Recent Comments

No comments to show.

Archives

  • September 2022
  • August 2022
  • May 2022
  • October 2020
  • June 2020

Categories

  • Uncategorized
© 2023 AiViva BioPharma | Powered by Beaver Builder
Scroll To Top